Maria G. Cabral

Lisbon, Portugal

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Increased Expression of HLA-DR and CD69 on Peripheral CD4+ T Cells Predicts Better Clinical Outcomes in Cutaneous Melanoma.

Increased Expression of HLA-DR and CD69 on Peripheral CD4+ T Cells Predicts Better Clinical Outcomes in Cutaneous Melanoma.

Journal: ImmunoTargets and therapy

Published: March 04, 2026

HLA-DR expression in cytotoxic T lymphocytes: a key to boost the therapeutic potential of T cell-based strategies for breast cancer.

HLA-DR expression in cytotoxic T lymphocytes: a key to boost the therapeutic potential of T cell-based strategies for breast cancer.

Journal: Frontiers in immunology

Published: June 25, 2025

A novel patient-derived cutaneous melanoma cell line reveals key features of metastatic melanoma.

A novel patient-derived cutaneous melanoma cell line reveals key features of metastatic melanoma.

Journal: Frontiers in oncology

Published: November 19, 2024

Cholesteryl hemiazelate identified in CVD patients causes in vitro and in vivo inflammation.

Cholesteryl hemiazelate identified in CVD patients causes in vitro and in vivo inflammation.

Journal: Journal of lipid research

Published: February 14, 2023

Urinary immune cell phenotype of severe AKI in critically ill patients.

Urinary immune cell phenotype of severe AKI in critically ill patients.

Journal: International urology and nephrology

Published: August 18, 2021

Circulating low density neutrophils of breast cancer patients are associated with their worse prognosis due to the impairment of T cell responses.

Circulating low density neutrophils of breast cancer patients are associated with their worse prognosis due to the impairment of T cell responses.

Journal: Oncotarget

Published: July 29, 2021

Development of Dl1.72, a Novel Anti-DLL1 Antibody with Anti-Tumor Efficacy against Estrogen Receptor-Positive Breast Cancer.

Development of Dl1.72, a Novel Anti-DLL1 Antibody with Anti-Tumor Efficacy against Estrogen Receptor-Positive Breast Cancer.

Journal: Cancers

Published: June 30, 2021

Expression of HLA-DR in Cytotoxic T Lymphocytes: A Validated Predictive Biomarker and a Potential Therapeutic Strategy in Breast Cancer.

Expression of HLA-DR in Cytotoxic T Lymphocytes: A Validated Predictive Biomarker and a Potential Therapeutic Strategy in Breast Cancer.

Journal: Cancers

Published: June 03, 2021

Evaluating SARS-CoV-2 Seroconversion Following Relieve of Confinement Measures.

Evaluating SARS-CoV-2 Seroconversion Following Relieve of Confinement Measures.

Journal: Frontiers in medicine

Published: October 08, 2020

Establishment of a 3D Co-culture With MDA-MB-231 Breast Cancer Cell Line and Patient-Derived Immune Cells for Application in the Development of Immunotherapies.

Establishment of a 3D Co-culture With MDA-MB-231 Breast Cancer Cell Line and Patient-Derived Immune Cells for Application in the Development of Immunotherapies.

Journal: Frontiers in oncology

Published: May 13, 2020

Longitudinal association of adiposity and high-sensitivity C-reactive protein from adolescence into early adulthood.

Longitudinal association of adiposity and high-sensitivity C-reactive protein from adolescence into early adulthood.

Journal: Nutrition, metabolism, and cardiovascular diseases : NMCD

Published: September 19, 2018

HLA-DR in Cytotoxic T Lymphocytes Predicts Breast Cancer Patients' Response to Neoadjuvant Chemotherapy.

HLA-DR in Cytotoxic T Lymphocytes Predicts Breast Cancer Patients' Response to Neoadjuvant Chemotherapy.

Journal: Frontiers in immunology

Published: July 20, 2018

Showing 1-12 of 17

Last Updated: 09/26/2026